DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Nakada T, Sugihara K, Jikoh T. et al.
The Latest Research and Development into the Antibody-Drug-Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a). for HER2 Cancer Therapy.
Chem Pharm Bull 2019;
67: 173-185
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.